BEAMSTART Logo

Can AI Unlock New Treatment Possibilities For Inflammatory Bowel Disease? How Johnson & Johnson Is Leading The Way

Forbes LogoForbes4d ago

Can AI Unlock New Treatment Possibilities For Inflammatory Bowel Disease? How Johnson & Johnson Is Leading The Way - Forbes

Quick Summary:

By merging data science with clinical expertise, ARGES provides a continuous disease severity score in UC, moving beyond the traditional categorical, human-read Mayo Endoscopic Subscore (MES), which sorts severity into fixed categories.

Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic assessment of disease activity in IBD.

ARGES’ approach can be thought of as switching from simple labels to precise measurements, much like considering how a student progresses over time rather than just assigning them a pass or fail grade.


More Pictures

Can AI Unlock New Treatment Possibilities For Inflammatory Bowel Disease? How Johnson & Johnson Is Leading The Way - Forbes (Picture 1)

or

Article Details

Author / Journalist: Johnson & Johnson Contributor, Brand Contributor

Category: StartupsTechnology

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-02-18 @ 09:39:30 (4 days ago)

News Timezone: GMT -5:00

News Source URL: forbes.com

Language: English

Article Length: 116 words

Reading Time: 1 minutes read

Sentences: 38 lines

Sentence Length: 4 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Forbes

News ID: 26254600

View Article Analysis

About Forbes

Forbes Logo

Main Topics: StartupsTechnology

Official Website: forbes.com

Update Frequency: 31 posts per day

Year Established: 1917

Headquarters: United States

News Last Updated: 13 hours ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT -5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #40

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "Can AI Unlock New Treatment Possibilities For Inflammatory Bowel Disease? How Johnson & Johnson Is Leading The Way" has 116 words across 38 sentences, which will take approximately 1 minutes for the average person to read.

Which news outlet covered this story?

The story "Can AI Unlock New Treatment Possibilities For Inflammatory Bowel Disease? How Johnson & Johnson Is Leading The Way" was covered 4 days ago by Forbes, a news publisher based in United States.

How trustworthy is 'Forbes' news outlet?

Forbes is a fully independent (privately-owned) news outlet established in 1917 that covers mostly startups and technology news.

The outlet is headquartered in United States and publishes an average of 31 news stories per day.

It's most recent story was published 13 hours ago.

What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #26254600
  • URL: https://beamstart.com/news/can-ai-unlock-new-treatment-17398896861215

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.